Comparison of the Efficacy, Tolerability and Safety of actiTENS to Those of Level 2 Analgesic Treatments.
Status:
Unknown status
Trial end date:
2019-10-31
Target enrollment:
Participant gender:
Summary
This is a phase 3, multicentre, prospective, single-blind on principal efficacy criterion, 2
parallel groups, randomized, controlled clinical study comparing efficacy and safety of
actiTENS versus systemic level 2 analgesics recommended for the treatment of moderate or
severe, nociceptive, chronic pain in patients suffering from osteoarthritis of the knee.